Skip to Main Content

Paper Details

From the prodromal stage of multiple sclerosis to disease prevention.
Nat Rev Neurol
19
2022
MS, Parkinson disease, multiple sclerosis, neurological and immune-mediated diseases, rheumatoid arthritis, schizophrenia, type 1 diabetes mellitus
Author NameAffiliation
Lisa F BarcellosSchool of Public Health, University of California Berkeley
Lisa F BarcellosKaiser Permanente Division of Research
Peter A CalabresiJohns Hopkins University School of Medicine
Philip L De JagerCenter for Translational & Computational Neuroimmunology, Columbia University Irving Medical Center
Philip L De JagerCenter for Translational & Computational Neuroimmunology, Columbia University Irving Medical Center
Carla J GreenbaumCenter for Interventional Immunology and Diabetes Program, Benaroya Research Institute
Bernhard HemmerTUM School of Medicine, Technical University of Munich
Bernhard Hemmer
Bernhard HemmerTUM School of Medicine, Technical University of Munich
Bernhard Hemmer
Shiv SaidhaJohns Hopkins University School of Medicine
  • 1 - 11

Datasets